The Manila Times on Nostr: WASHINGTON, D.C. — A closely watched Alzheimer's drug from Eli Lilly won the ...
WASHINGTON, D.C. — A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild dementia caused by the brain-robbing disease.
READ:
https://tmt.news/1950947Published at
2024-06-11 02:01:17Event JSON
{
"id": "11c379d1dc061b9f238aaa5c92f60f4522f3329769becae6a66b9a775da95cbc",
"pubkey": "12a6e1a586f38a80c75177284e7fc849f3f0e7e20eb90fbc409c7cf044b016dd",
"created_at": 1718071277,
"kind": 1,
"tags": [
[
"proxy",
"https://mastodon.social/users/TheManilaTimes/statuses/112595519223523678",
"activitypub"
]
],
"content": "WASHINGTON, D.C. — A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild dementia caused by the brain-robbing disease.\n\nREAD: https://tmt.news/1950947",
"sig": "45cac18b861d05897b4768ca487feea9e622faeeedea49b4132837c4bb572ec984538b0a0bd6f9520926cfd0d8e2471cfb95df1dccc0868ca1ddf95cb4ae22dd"
}
